175 related articles for article (PubMed ID: 11971895)
1. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins.
Liang CL; Chen JL; Hsu YP; Ou JT; Chang YS
J Biol Chem; 2002 Jun; 277(26):23345-57. PubMed ID: 11971895
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
Iempridee T; Das S; Xu I; Mertz JE
J Virol; 2011 Aug; 85(15):7836-48. PubMed ID: 21593157
[TBL] [Abstract][Full Text] [Related]
4. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
Sato H; Takeshita H; Furukawa M; Seiki M
J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.
Qing J; Zhang Y; Derynck R
J Biol Chem; 2000 Dec; 275(49):38802-12. PubMed ID: 10995748
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
8. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
[TBL] [Abstract][Full Text] [Related]
9. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
10. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
Yamamura Y; Hua X; Bergelson S; Lodish HF
J Biol Chem; 2000 Nov; 275(46):36295-302. PubMed ID: 10942775
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
13. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
14. Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.
Liu P; Liu S; Speck SH
J Virol; 1998 Oct; 72(10):8230-9. PubMed ID: 9733866
[TBL] [Abstract][Full Text] [Related]
15. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
16. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
[TBL] [Abstract][Full Text] [Related]
17. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
[TBL] [Abstract][Full Text] [Related]
18. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
Nagata Y; Inoue H; Yamada K; Higashiyama H; Mishima K; Kizu Y; Takeda I; Mizuno F; Hayashi Y; Saito I
Immunology; 2004 Feb; 111(2):223-9. PubMed ID: 15027908
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
Yue J; Mulder KM
J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta/Smads signaling induces transcription of the cell type-restricted ankyrin repeat protein CARP gene through CAGA motif in vascular smooth muscle cells.
Kanai H; Tanaka T; Aihara Y; Takeda S; Kawabata M; Miyazono K; Nagai R; Kurabayashi M
Circ Res; 2001 Jan; 88(1):30-6. PubMed ID: 11139470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
